Breast cancer remains the most prevalent malignancy among women and the second leading cause of cancer-related deaths in American women. Early detection through screening mammograms is crucial for improving survival rates. This article delves into the importance of breast cancer screening, the statistics behind it, and the ongoing debate about over-diagnosis and over-treatment.
Breast cancer is a significant health concern. According to the American Cancer Society, in 2023, an estimated 297,790 new cases of invasive breast cancer will be diagnosed in women in the U.S., along with 55,720 new cases of non-invasive (in situ) breast cancer. Tragically, approximately 43,700 women are expected to die from the disease this year [^1^].
For women of average risk, the lifetime probability of developing breast cancer is about 1 in 8 (12.5%) [^2^]. This statistic underscores the importance of regular screening and early detection.
From 1990 to 2018, the breast cancer death rate in the U.S. decreased by 40%, largely due to early detection through screening mammograms and improved treatments [^3^]. Early detection allows for more effective treatment options and significantly increases the chances of survival.
Several large-scale studies have demonstrated the efficacy of screening mammograms. One of the most notable is the Swedish Two-County Trial, which involved 133,065 women aged 40-74 years. The study, published in the journal Radiology in 2011, found a 31% reduction in breast cancer mortality among women invited to undergo screening [^4^]. The authors estimated that screening 300 women for 10 years could prevent one death from breast cancer.
While the Swedish study provides compelling evidence, it's important to note that the actual benefit of screening mammography may be even greater for women who consistently undergo testing. In large population studies, some women invited to screen do not participate, and some women not invited still get mammograms, albeit less frequently.
Screening mammograms can sometimes detect abnormalities that lead to biopsies, which may turn out to be benign or pre-cancerous. This phenomenon, known as over-diagnosis, can cause anxiety, discomfort, and additional healthcare costs. Critics argue that not all detected abnormalities would progress to invasive cancer if left untreated.
Similarly, screening can identify tiny cancers that might be treated with surgery, radiation, anti-estrogen pills, or chemotherapy. Critics refer to this as over-treatment, as it is challenging to determine with absolute certainty which small cancers would become life-threatening without intervention.
Despite these concerns, the benefits of screening mammograms in reducing breast cancer mortality are well-documented. The current recommendation is for annual screening mammograms starting at age 40. Each woman must weigh the proven reduction in mortality against the potential inconvenience and side effects of over-diagnosis and over-treatment.
Breast cancer screening through mammograms has significantly contributed to the decline in breast cancer mortality rates. While the debate over over-diagnosis and over-treatment continues, the evidence supports the life-saving potential of regular screening. Women should make informed decisions about their health, considering both the benefits and the risks.
[^1^]: American Cancer Society [^2^]: National Cancer Institute [^3^]: Centers for Disease Control and Prevention [^4^]: Radiology Journal
This article provides a comprehensive overview of breast cancer screening, emphasizing the importance of early detection and the ongoing discussions about the implications of screening practices.
What every woman should know about ovarian cancer
Please read here to learn some basic facts about ovarian cancer, a most deadly disease in women. This can save your life!
Should chest CT be used to screen for lung cancer?
Please read here the guidelines for lung cancer screening and detection. This can save your life!
What to do if you have the hereditary breast and ovarian cancer gene BRCA
Once you have been diagnosed with having a problem with the hereditary breast and ovarian cancer gene BRCA, you need to take active steps to reduce your risk of developing early cancers.
